Archives
-
Oligo-dT Membrane Design for mRNA Capture
2026-09-14
The reference study establishes design rules for improving oligo-dT affinity membranes by linking ligand density, nanoscale clustering, pore size, and mRNA dimensions. Its local-density model and super-resolution measurements show why excess ligand does not necessarily improve capture and provide practical guidance for purifying long polyadenylated transcripts.
-
Ouabain at the Vascular Translation Frontier
2026-09-14
Ouabain is more than a classical sodium-potassium pump blocker: it is a mechanistic probe for testing how ion gradients, calcium handling, and vascular reserve interact across translational models. This article connects Ouabain-based perturbation strategies with recent findings on metformin-driven endothelium-dependent hyperpolarization, while providing practical guidance for cardiovascular research, assay design, and heart failure model interpretation.
-
LY364947 for TGF-β Signaling and EMT
2026-09-13
LY364947 is a selective TGF-β type I receptor kinase inhibitor for connecting proximal Smad2 signaling to EMT, fibrosis, cancer, and retinal injury phenotypes. This workflow shows how to manage DMSO stocks, pair rapid phospho-readouts with longer EMT endpoints, and interpret pathway effects alongside the latest pancreatic cancer findings.
-
HyperScribe™ Poly (A) Tailing Kit Workflow
2026-09-12
Build more consistent RNA workflows by adding a defined poly(A) tail to HyperScribe T7 transcripts before translation, transfection, or micro-injection. This practical guide connects tailing control with the chemically modified mRNA strategy used in a thrombopoietin mouse study while separating established evidence from conditions that require laboratory optimization.
-
Thiazovivin (A5506): Practical ROCK Inhibitor Guide
2026-09-11
Thiazovivin is a ROCK inhibitor for workflows in which dissociation-related cell loss or inefficient fibroblast reprogramming limits results. This guide covers stock handling, control design, and QC for induced pluripotent stem cell generation and human embryonic stem cell survival, while defining why the compound should remain within validated research workflows and not be used for diagnostic or clinical purposes.
-
Protecting CerS6 Biology During Protein Extraction
2026-09-11
CerS6 activity depends on more than protein abundance: the reference study links basal Asn18 glycosylation to catalytic function and downstream signaling. This article translates that insight into a practical extraction strategy using an EDTA-free protease inhibitor cocktail while defining what such protection can—and cannot—prove.
-
Multiplex PBMC Assay for Immunomodulator Screening
2026-09-10
Brox and Hackstein developed a human PBMC-based multiplex flow cytometry assay that measures T-cell proliferation and activation alongside B-cell costimulatory responses. Its use of defined stimulation conditions, multiparametric readouts, and Z-factor validation offers a practical framework for higher-resolution immunomodulator screening and immune pathway profiling.
-
O-propargyl-puromycin (OPP) for Translation Flux
2026-09-10
O-propargyl-puromycin (OPP) converts nascent protein synthesis into a measurable click-chemistry signal. This article explains how to use OPP to interrogate the Pcbp1–Fdxr–mitochondrial axis in B cells while distinguishing translation flux from mitochondrial function and cell viability.
-
Vernakalant Hydrochloride: Atrial Selectivity in Practice
2026-09-09
Vernakalant Hydrochloride, also known as RSD1235, offers a useful model for studying atrial-selective multichannel pharmacology. This article explains how ion-channel selectivity, exposure matching, and KCa2 assay controls improve atrial fibrillation research decisions.
-
Dextrose and Hypoxic Tumor Immunometabolism
2026-09-09
Dextrose (D-glucose) is more than a routine nutrient: it is a controllable variable for studying glucose metabolism research, hypoxia, and immune-cell competition. This article translates tumor immunometabolism concepts into practical assay-design and reagent-handling decisions.
-
GKT137831: Dual Nox1/Nox4 Inhibitor Workflows
2026-09-08
GKT137831 supports mechanism-focused studies of Nox1/Nox4-driven oxidative stress across pulmonary vascular, hepatic, metabolic, and cardiovascular models. This guide combines practical dosing workflows with a cautious extension into ferroptosis research, where membrane damage and lipid scrambling provide complementary assay endpoints.
-
E-4031 for 3D hERG Electrophysiology
2026-09-08
E-4031 provides a defined hERG potassium channel blockade challenge for linking repolarization changes to three-dimensional conduction behavior in cardiac organoids. Combined with shell microelectrode arrays, it supports spatially resolved QT-like field-potential analysis, calcium validation, and proarrhythmic substrate modeling beyond conventional planar assays.
-
Medroxyprogesterone acetate in Decidualization Research
2026-09-07
Use Medroxyprogesterone acetate as a controlled progestin perturbation across endometrial, renal, and neuroendocrine models. This workflow connects MPA dose-response testing with vitamin D/VDR decidualization assays while emphasizing solubility control, receptor-aware interpretation, and reproducible troubleshooting.
-
Ciprofloxacin Hydrochloride in Single-Cell Assays
2026-09-07
Ciprofloxacin hydrochloride is more than a routine fluoroquinolone antibiotic: it is a practical probe for DNA damage, bacterial survival, and antibiotic interaction studies. This guide translates single-cell findings into reproducible workflows, formulation choices, comparative assay designs, and troubleshooting strategies.
-
Pam3CSK4 for Reliable TLR1/2 Assays
2026-09-05
Learn how Pam3CSK4 (SKU A9920) can improve interpretation of cell viability, proliferation, and inflammatory-response assays through defined TLR1/2 stimulation and disciplined handling. This scenario-based guide connects assay controls, preparation, neuro-immune interpretation, and practical product selection.